Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?

Asthma is a prevalent chronic heterogeneous inflammatory disease of the airways, leading to reversible airway obstruction, in which various inflammatory responses can be observed. Mild to moderate asthma patients often present with a Th2-mediated eosinophilic inflammation whereas in severe asthma pa...

Full description

Bibliographic Details
Main Authors: Heleen Vroman, Rudi W. Hendriks, Mirjam Kool
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2017.00941/full
_version_ 1811339968979664896
author Heleen Vroman
Rudi W. Hendriks
Mirjam Kool
author_facet Heleen Vroman
Rudi W. Hendriks
Mirjam Kool
author_sort Heleen Vroman
collection DOAJ
description Asthma is a prevalent chronic heterogeneous inflammatory disease of the airways, leading to reversible airway obstruction, in which various inflammatory responses can be observed. Mild to moderate asthma patients often present with a Th2-mediated eosinophilic inflammation whereas in severe asthma patients, a Th17-associated neutrophilic or combined Th2 and Th17-mediated eosinophilic/neutrophilic inflammation is observed. The differentiation of these effector Th2 and Th17-cells is induced by allergen-exposed dendritic cells (DCs) that migrate toward the lung draining lymph node. The DC lineage comprises conventional DCs (cDCs) and plasmacytoid DCs (pDCs), of which the cDC lineage consists of type 1 cDCs (cDC1s) and cDC2s. During inflammation, also monocytes can differentiate into so-called monocyte-derived DCs (moDCs). These DC subsets differ both in ontogeny, localization, and in their functional properties. New identification tools and the availability of transgenic mice targeting specific DC subsets enable the investigation of how these different DC subsets contribute to or suppress asthma pathogenesis. In this review, we will discuss mechanisms used by different DC subsets to elicit or hamper the pathogenesis of both Th2-mediated eosinophilic asthma and more severe Th17-mediated neutrophilic inflammation.
first_indexed 2024-04-13T18:34:29Z
format Article
id doaj.art-9fcdb0de06ca4ccdb92f1f4a8d5db3a8
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-13T18:34:29Z
publishDate 2017-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9fcdb0de06ca4ccdb92f1f4a8d5db3a82022-12-22T02:34:56ZengFrontiers Media S.A.Frontiers in Immunology1664-32242017-08-01810.3389/fimmu.2017.00941282856Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?Heleen Vroman0Rudi W. Hendriks1Mirjam Kool2Department of Pulmonary Medicine, Erasmus MC, Rotterdam, NetherlandsDepartment of Pulmonary Medicine, Erasmus MC, Rotterdam, NetherlandsDepartment of Pulmonary Medicine, Erasmus MC, Rotterdam, NetherlandsAsthma is a prevalent chronic heterogeneous inflammatory disease of the airways, leading to reversible airway obstruction, in which various inflammatory responses can be observed. Mild to moderate asthma patients often present with a Th2-mediated eosinophilic inflammation whereas in severe asthma patients, a Th17-associated neutrophilic or combined Th2 and Th17-mediated eosinophilic/neutrophilic inflammation is observed. The differentiation of these effector Th2 and Th17-cells is induced by allergen-exposed dendritic cells (DCs) that migrate toward the lung draining lymph node. The DC lineage comprises conventional DCs (cDCs) and plasmacytoid DCs (pDCs), of which the cDC lineage consists of type 1 cDCs (cDC1s) and cDC2s. During inflammation, also monocytes can differentiate into so-called monocyte-derived DCs (moDCs). These DC subsets differ both in ontogeny, localization, and in their functional properties. New identification tools and the availability of transgenic mice targeting specific DC subsets enable the investigation of how these different DC subsets contribute to or suppress asthma pathogenesis. In this review, we will discuss mechanisms used by different DC subsets to elicit or hamper the pathogenesis of both Th2-mediated eosinophilic asthma and more severe Th17-mediated neutrophilic inflammation.http://journal.frontiersin.org/article/10.3389/fimmu.2017.00941/fullasthmadendritic cellsTh2 cellsTh17 cellsairway inflammation
spellingShingle Heleen Vroman
Rudi W. Hendriks
Mirjam Kool
Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
Frontiers in Immunology
asthma
dendritic cells
Th2 cells
Th17 cells
airway inflammation
title Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
title_full Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
title_fullStr Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
title_full_unstemmed Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
title_short Dendritic Cell Subsets in Asthma: Impaired Tolerance or Exaggerated Inflammation?
title_sort dendritic cell subsets in asthma impaired tolerance or exaggerated inflammation
topic asthma
dendritic cells
Th2 cells
Th17 cells
airway inflammation
url http://journal.frontiersin.org/article/10.3389/fimmu.2017.00941/full
work_keys_str_mv AT heleenvroman dendriticcellsubsetsinasthmaimpairedtoleranceorexaggeratedinflammation
AT rudiwhendriks dendriticcellsubsetsinasthmaimpairedtoleranceorexaggeratedinflammation
AT mirjamkool dendriticcellsubsetsinasthmaimpairedtoleranceorexaggeratedinflammation